Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TNYA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
213,478,610
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34,529,364
Holdings value
$55,547,746
% of all portfolios
0%
Number of holders
89
Number of buys
34
Number of sells
-47
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COLUMN GROUP III, LP 23.1% -24% $67,066,440 49,313,559 0% The Column Group Opportunity III, LP 15 Dec 2025
Woodline Partners LP 4.99% -25.9% $6,120,000 +$2,097,006 9,000,000 +52.1% Woodline Partners LP 30 Jun 2025
Empery Asset Management, LP 4.99% -49.7% $5,641,468 -$293,106 8,296,276 -4.9% Empery Asset Management, LP 30 Jun 2025
Casdin Capital, LLC 4.3% $3,231,826 6,732,971 Casdin Capital, LLC 04 Mar 2025
BlackRock, Inc. 1.7% -71.4% $1,670,287 -$1,566,919 2,732,800 -48.4% BlackRock, Inc. 30 Jun 2025
JPMORGAN CHASE & CO 2.8% -52.9% $1,096,279 -$1,378,097 2,283,914 -55.7% JPMORGAN CHASE & CO. 28 Feb 2025

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34,529,364 $55,547,746 +$5,329,372 $1.62 89
2025 Q2 31,571,002 $19,291,816 -$9,941,570 $0.6112 87
2025 Q1 48,166,604 $27,453,207 +$1,982,469 $0.5701 104
2024 Q4 43,606,618 $62,359,118 -$25,849,595 $1.43 83
2024 Q3 57,630,896 $111,228,656 +$67,017 $1.93 91
2024 Q2 57,076,933 $176,981,415 +$2,253,617 $3.1 94
2024 Q1 56,023,483 $292,935,438 +$51,188,426 $5.23 89
2023 Q4 46,629,309 $151,075,893 -$9,232,276 $3.24 73
2023 Q3 49,741,215 $126,838,955 -$3,313,935 $2.55 77
2023 Q2 47,651,950 $279,717,125 +$15,890,634 $5.87 79
2023 Q1 45,028,141 $128,326,772 -$2,290,501 $2.85 65
2022 Q4 47,128,809 $94,724,321 +$22,977,493 $2.01 67
2022 Q3 35,221,703 $102,151,001 -$12,249,474 $2.9 67
2022 Q2 37,062,342 $208,638,443 -$1,855,716 $5.63 47
2022 Q1 37,349,150 $439,920,087 +$23,331,598 $11.78 50
2021 Q4 35,354,543 $667,600,957 +$18,069,398 $18.95 46
2021 Q3 24,450,664 $499,284,447 +$499,284,447 $20.65 44